{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:00:59Z","timestamp":1779242459720,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to evaluate and determine the effect of diabetes mellitus (DM) on overall survival (OS) and cancer-specific survival (CSS) in early stage cervical cancer (CC) patients. Patients with primary cervical cancer and newly diagnosed were selected from ten different cancer specialist hospitals of Malaysia. Patients\u2019 demographic and clinical data were obtained for the prognostic analysis. Kaplan-Meier method was used to estimate patients\u2019 survival time (CSS and OS) with DM status and values were compared using the log-rank test. A total of 19,785 newly diagnosed CC patients were registered during 2010\u20132016, among them only 16,946 (85.6%) with primary CC tumor. There was no difference in treatment modality between DM and non-DM patients. However intergroup assessment showed that type 2DM have significantly higher rate of mortality in both overall mortality (28.3%) and CC-specific (11.7%) as compared to Type 1DM (17.3%; 5.5%) and non DM patients (12.7%; 9.1%) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Within group assessments showed that Type 2DM patients have better quality of life (mean 7.13\u2009\u00b1\u20093.67) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and less distress levels (mean 2.41\u2009\u00b1\u20090.63) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.011) as compared to type1 DM (meant 10.54\u2009\u00b1\u20092.11; 3.19\u2009\u00b1\u20091.07). This study concluded that T2DM prognostic effect still remained after adjusting demographic and clinical parameters. Type 1 diabetes mellitus showed better OS and CSS then type2 DM.<\/jats:p>","DOI":"10.1038\/s41598-018-37694-1","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T11:04:33Z","timestamp":1548932673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multivariate Analysis on the Effects of Diabetes and related Clinical Parameters on Cervical Cancer Survival Probability"],"prefix":"10.1038","volume":"9","author":[{"given":"Syed Wasif","family":"Gillani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham A.","family":"Zaghloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan Altaf","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohi Iqbal Mohammad","family":"Abdul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Azhar Syed","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirza R.","family":"Baig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassaan Anwar","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"37694_CR1","unstructured":"Globocan. Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012 [Internet]. International Agency for Research on Cancer (IARC); 2012. Preprint at, http:\/\/globocan.iarc.fr\/old\/FactSheets\/cancers\/cervix-new.asp (2015)."},{"issue":"18","key":"37694_CR2","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","volume":"92","author":"M Frisch","year":"2000","unstructured":"Frisch, M. Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome. J Natl Cancer Inst. 92(18), 1500\u201310 (2000).","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"37694_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/jnci\/djj010","volume":"98","author":"SE Hawes","year":"2006","unstructured":"Hawes, S. E. et al. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst. 98(2), 100\u20139 (2006).","journal-title":"J Natl Cancer Inst."},{"key":"37694_CR4","unstructured":"World Health Organization (WHO). Comprehensive cervical cancer prevention and control: a healthier future for girls and women [Internet]. 2013. Preprint at, http:\/\/apps.who.int\/iris\/bitstream\/10665\/78128\/3\/9789241505147_eng.pdf?ua=1 (2015)."},{"issue":"Suppl C","key":"37694_CR5","first-page":"63","volume":"63","author":"BCR Devi","year":"2008","unstructured":"Devi, B. C. R., Tang, T. S. & Gerard, L. C. Preliminary results from the pilot study on the National Cancer Patient Registry\u2013Cervical Cancer. Med J Malaysia. 63(Suppl C), 63\u201365 (2008).","journal-title":"Med J Malaysia."},{"key":"37694_CR6","unstructured":"Bruni, L. et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Malaysia. Summary Report 27 July 2017. Preprint at, http:\/\/www.hpvcentre.net\/statistics\/reports\/XWX.pdf (2017)."},{"issue":"Supplement A","key":"37694_CR7","first-page":"33","volume":"69","author":"S Zaridah","year":"2014","unstructured":"Zaridah, S. A Review of Cervical Cancer Research in Malaysia. Med J Malaysia. 69(Supplement A), 33\u201341 (2014).","journal-title":"Med J Malaysia."},{"key":"37694_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","volume":"65","author":"M Rotman","year":"2006","unstructured":"Rotman, M. et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 65, 169\u2013176 (2006).","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"37694_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/ERC-09-0087","volume":"16","author":"P Vigneri","year":"2009","unstructured":"Vigneri, P. et al. Diabetes and cancer. Endocr Relat Cancer. 16, 1103\u20131123 (2009).","journal-title":"Endocr Relat Cancer."},{"key":"37694_CR10","first-page":"12","volume":"3","author":"MU Yood","year":"2009","unstructured":"Yood, M. U. et al. Incidence of cancer in a population-based cohort of patients with type 2 diabetes. Diab Met Syndr Clin Res Rev. 3, 12\u201316 (2009).","journal-title":"Diab Met Syndr Clin Res Rev."},{"key":"37694_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ijc.25362","volume":"128","author":"EA Atchison","year":"2011","unstructured":"Atchison, E. A. et al. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer. 128, 635\u2013643 (2011).","journal-title":"Int J Cancer."},{"key":"37694_CR12","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-08-2755","volume":"68","author":"JH Law","year":"2008","unstructured":"Law, J. H. et al. Phosphorylated insulin-like growth factor-i\/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res. 68, 10238\u201310246 (2008).","journal-title":"Cancer Res."},{"key":"37694_CR13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/carcin\/bgi336","volume":"27","author":"MR Shen","year":"2006","unstructured":"Shen, M. R. et al. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Carcinogenesis. 27, 962\u2013971 (2006).","journal-title":"Carcinogenesis."},{"key":"37694_CR14","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/sj.bjc.6604661","volume":"99","author":"YF Huang","year":"2008","unstructured":"Huang, Y. F. et al. Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer. Br J Cancer. 99, 1096\u20131102 (2008).","journal-title":"Br J Cancer."},{"key":"37694_CR15","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","volume":"89","author":"L Wideroff","year":"1997","unstructured":"Wideroff, L. et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 89, 1360\u20131365 (1997).","journal-title":"J Natl Cancer Inst."},{"key":"37694_CR16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1634\/theoncologist.2012-0065","volume":"17","author":"WY Shau","year":"2012","unstructured":"Shau, W. Y. et al. Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma. The Oncologist. 17, 856\u2013862 (2012).","journal-title":"The Oncologist."},{"key":"37694_CR17","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1158\/1078-0432.CCR-08-2980","volume":"15","author":"C Desbois-Mouthon","year":"2009","unstructured":"Desbois-Mouthon, C. et al. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor\/HER3\/AKT signaling pathway: Rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Clin Cancer Res. 15, 5445\u20135456 (2009).","journal-title":"Clin Cancer Res."},{"key":"37694_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.humpath.2004.09.005","volume":"35","author":"C Shimizu","year":"2004","unstructured":"Shimizu, C. et al. Expression of insulin-like growth factor 1 receptor in primary breast cancer: Immunohistochemical analysis. Hum Pathol. 35, 1537\u20131542 (2004).","journal-title":"Hum Pathol."},{"key":"37694_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3802\/jgo.2010.21.3.174","volume":"21","author":"SW Lee","year":"2010","unstructured":"Lee, S. W. et al. Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia. J Gynecol Oncol. 21, 174\u2013180 (2010).","journal-title":"J Gynecol Oncol."},{"key":"37694_CR20","first-page":"1761","volume":"56","author":"MA Steller","year":"1996","unstructured":"Steller, M. A. et al. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Cancer Res. 56, 1761\u20131765 (1996).","journal-title":"Cancer Res."},{"key":"37694_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.surg.2012.12.004","volume":"153","author":"M Luo","year":"2013","unstructured":"Luo, M. et al. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery. 153, 836\u2013847 (2013).","journal-title":"Surgery."},{"key":"37694_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1634\/theoncologist.2015-0111","volume":"20","author":"HY Kuo","year":"2015","unstructured":"Kuo, H. Y. et al. The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia. The Oncologist. 20, 1051\u20131057 (2015).","journal-title":"The Oncologist."},{"key":"37694_CR23","doi-asserted-by":"crossref","first-page":"18868","DOI":"10.1016\/S0021-9258(18)55144-9","volume":"266","author":"DR Powell","year":"1991","unstructured":"Powell, D. R. et al. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem. 266, 18868\u201318876 (1991).","journal-title":"J Biol Chem."},{"key":"37694_CR24","first-page":"2219","volume":"6","author":"GT Ooi","year":"1992","unstructured":"Ooi, G. T. et al. Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol Endocrinol. 6, 2219\u20132228 (1992).","journal-title":"Mol Endocrinol."},{"key":"37694_CR25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/AOG.0000000000000558","volume":"124","author":"M Frumovitz","year":"2014","unstructured":"Frumovitz, M. et al. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 124, 1098\u20131104 (2014).","journal-title":"Obstet Gynecol."},{"key":"37694_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2008.07.049","volume":"75","author":"JR Wong","year":"2009","unstructured":"Wong, J. R. et al. Potential for higher treatment failure in obese patients: Correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images. Int J Radiat Oncol Biol Phys. 75, 49\u201355 (2009).","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"37694_CR27","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","volume":"30","author":"JJ Griggs","year":"2012","unstructured":"Griggs, J. J. et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 30, 1553\u20131561 (2012).","journal-title":"J Clin Oncol."},{"key":"37694_CR28","unstructured":"Greene, F. L. et al. AJCC Cancer Staging Handbook. 6th ed. New York, NY: 100\u2013165 (Springer, 2002)."},{"key":"37694_CR29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo, R. A., Cherkin, D. C. & Ciol, M. A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 45, 613\u2013619 (1992).","journal-title":"J Clin Epidemiol."},{"issue":"3","key":"37694_CR30","first-page":"199","volume":"13","author":"EuroQOL","year":"1990","unstructured":"EuroQOL. Euro-QOL \u2013 a new facility for the measurement of health-related quality of life. Health Policy. 13(3), 199\u2013208 (1990).","journal-title":"Health Policy."},{"key":"37694_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2337\/dc11-1572","volume":"35","author":"L Fisher","year":"2012","unstructured":"Fisher, L., Hessler, D. M., Polonsky, W. H. & Mullan, J. When is diabetes distress clinically meaningful? Establishing cut-points for the Diabetes Distress Scale. Diabetes Care. 35, 259\u2013264 (2012).","journal-title":"Diabetes Care."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37694-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37694-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37694-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:24:03Z","timestamp":1671254643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37694-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37694"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37694-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"20 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1084"}}